Quantitation of vervet monkey (Chlorocebus aethiops) plasminogen activator inhibitor-I in plasma and platelets [1]

Thrombosis and Haemostasis

Volumn 95, Issue 5, 2006, Pages 902-903

  Meissenheimer, Lester M ^a   Verbeke, Koen ^a   Declerck, Paul J ^a   Gils, Ann ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HALF LIFE TIME; LETTER; MALE; MOLECULAR CLONING; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; STATISTICAL SIGNIFICANCE; STUDENT T TEST; THROMBOCYTE; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

ANIMALS; ANTIGENS; BLOOD PLATELETS; CERCOPITHECUS AETHIOPS; DNA, COMPLEMENTARY; KINETICS; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 33646456629     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-11-0765     Document Type: Letter

References (12)

1. Declerck PJ, De Mol M, Vaughan DE, et al. Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator. J Biol Chem 1992; 267: 11693-6.
2. Declerck PJ, De Mol M, Alessi MC, et al. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 1988; 263: 15454-61.
3. Hekman CM, Loskutoff DJ. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem 1985; 260: 11581-7.
4. Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2005; 3: 35-45.
5. Fincham JE, Woodroof CW, van Wyk MJ, et al. Promotion and regression of atherosclerosis in vervet monkeys by diets realistic for westernized people. Atherosclerosis 1987; 66: 205-13.
6. Gils A, Knockaert I, Declerck PJ. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop. Biochemistry 1996; 35: 7474-81.
7. Gils A, Declerck PJ. The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb Haemost 2004; 91: 425-37.
8. Leng HM, Brouwers E, Knockaert I, et al. Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples. Thromb Haemost 2000; 84: 1082-6.
9. Declerck PJ, Alessi MC, Verstreken M, et al. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220-5.
10. Ngo TH, Verheyen S, Knockaert I, et al. Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples. Thromb Haemost 1998; 79: 808-12.
11. Ngo TH, Declerck PJ. Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples. Evidence that rabbit platelets do not contain PAI-1. Thromb Haemost 1999; 82: 1510-5.
12. Declerck PJ, Verstreken M, Collen D. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 1995; 74: 1305-9.